Toggle navigation
HOME
MANAGEMENT
BUSINESS SEGMENTS
PRODUCTS & SERVICES
API
Dosage Form
CRAMS
Licensing
Medical Tourism
INFRASTRUCTURE
R&D
Manufacturing Plants
CSR
GOVERNANCE
CONTACT US
HOME
MANAGEMENT
BUSINESS SEGMENTS
PRODUCTS & SERVICES
API
Dosage Form
CRAMS
Licensing
Medical Tourism
INFRASTRUCTURE
R&D
Manufacturing Plants
CSR
GOVERNANCE
CONTACT US
ALL NEWSLETTERS
December 2020
Domestic Vaccines Boost Chinese Society’s Confidence in Local Pharma
Read full Newsletter
November 2020
Vaccines: 200 years of progress and scepticism
Read full Newsletter
October 2020
Govt Identifying 30 Crore Priority Beneficiaries for Covid Vaccine, St
Read full Newsletter
September 2020
Covid-19 Vaccination 'Mother of Planning Exercises', Data Should be...
Read full Newsletter
August 2020
Covaxin, India’s 1st Coronavirus Vaccine, May be Available by End...
Read full Newsletter
July 2020
FDA Chief Refuses To Back Trump's Vaccine Prediction
Read full Newsletter
June 2020
Bangladesh Pharma Giant To Sell First Generic Version of Remdesivir...
Read full Newsletter
May 2020
Chinese Scientists Believe New Drug Can Stop Covid-19 'Without...
Read full Newsletter
April 2020
COVID-19 Pandemic Leaves the Private Healthcare Sector in Financial Di
Read full Newsletter
March 2020
India, US Collaborating in Diagnostics to Fight Covid-19: Ambassador
Read full Newsletter
February 2020
Coronavirus Impact: India's Dependence on Chinese APIs May Lead to...
Read full Newsletter
January 2020
Mission 2020, A Revised Agenda for Indian Pharma
Read full Newsletter
1
2
3
© Copyright 2020 - All Rights Reserved Reva Pharma.
